CSAM Health Group AS
CSAMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | -0.05 | -0.14 | -0.01 |
| FCF Yield | 7.97% | -0.74% | -3.06% | -0.75% |
| EV / EBITDA | 26.16 | 6.06 | -125.53 | 52.09 |
| Quality | ||||
| ROIC | -0.57% | 23.12% | -15.89% | -5.82% |
| Gross Margin | 92.70% | 92.20% | 90.90% | 89.26% |
| Cash Conversion Ratio | -2.20 | 0.38 | -0.09 | -0.25 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.04% | 7.62% | 17.07% | 140.73% |
| Free Cash Flow Growth | 1,285.73% | 75.38% | -354.22% | -967.41% |
| Safety | ||||
| Net Debt / EBITDA | 6.43 | 1.60 | -29.47 | 10.19 |
| Interest Coverage | -0.05 | 2.57 | -2.43 | -1.57 |
| Efficiency | ||||
| Inventory Turnover | 121.69 | 681.06 | 102.08 | 5,052.57 |
| Cash Conversion Cycle | -230.06 | -201.23 | -43.35 | -102.87 |